Keybank National Association OH Decreases Position in Amdocs Limited (NASDAQ:DOX)

Keybank National Association OH cut its position in Amdocs Limited (NASDAQ:DOX) by 3.7% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 7,189 shares of the technology company’s stock after selling 277 shares during the period. Keybank National Association OH’s holdings in Amdocs were worth $612,000 as of its most recent SEC filing.

Other large investors have also bought and sold shares of the company. Pzena Investment Management LLC raised its holdings in shares of Amdocs by 12.3% during the third quarter. Pzena Investment Management LLC now owns 6,363,739 shares of the technology company’s stock valued at $556,700,000 after purchasing an additional 696,136 shares during the last quarter. Hotchkis & Wiley Capital Management LLC raised its holdings in shares of Amdocs by 123.2% during the third quarter. Hotchkis & Wiley Capital Management LLC now owns 759,136 shares of the technology company’s stock valued at $66,409,000 after purchasing an additional 419,045 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in shares of Amdocs by 1,207.3% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 271,701 shares of the technology company’s stock valued at $23,768,000 after purchasing an additional 250,918 shares during the last quarter. Geode Capital Management LLC raised its holdings in shares of Amdocs by 10.8% during the third quarter. Geode Capital Management LLC now owns 1,633,733 shares of the technology company’s stock valued at $143,498,000 after purchasing an additional 158,843 shares during the last quarter. Finally, Nordea Investment Management AB raised its holdings in shares of Amdocs by 8.3% during the fourth quarter. Nordea Investment Management AB now owns 1,656,055 shares of the technology company’s stock valued at $141,112,000 after purchasing an additional 127,426 shares during the last quarter. 92.02% of the stock is owned by hedge funds and other institutional investors.

Amdocs Stock Performance

DOX opened at $90.46 on Friday. The firm has a market cap of $10.21 billion, a P/E ratio of 20.99, a PEG ratio of 1.47 and a beta of 0.68. Amdocs Limited has a 1-year low of $74.41 and a 1-year high of $94.04. The company has a 50 day simple moving average of $86.36 and a two-hundred day simple moving average of $86.96. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.16 and a quick ratio of 1.20.

Amdocs (NASDAQ:DOX) last posted its quarterly earnings results on Tuesday, February 4th. The technology company reported $1.45 earnings per share for the quarter, missing analysts’ consensus estimates of $1.64 by ($0.19). Amdocs had a return on equity of 18.89% and a net margin of 10.19%. Equities analysts forecast that Amdocs Limited will post 6.21 earnings per share for the current fiscal year.

Amdocs Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Monday, March 31st will be given a $0.527 dividend. This is a positive change from Amdocs’s previous quarterly dividend of $0.48. This represents a $2.11 dividend on an annualized basis and a dividend yield of 2.33%. The ex-dividend date of this dividend is Monday, March 31st. Amdocs’s dividend payout ratio is presently 48.72%.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on DOX shares. StockNews.com cut shares of Amdocs from a “strong-buy” rating to a “buy” rating in a report on Friday, February 28th. Barclays cut their target price on shares of Amdocs from $113.00 to $111.00 and set an “overweight” rating for the company in a research report on Thursday, November 14th. Finally, Oppenheimer boosted their target price on shares of Amdocs from $98.00 to $105.00 and gave the company an “outperform” rating in a research report on Wednesday, November 13th. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $101.20.

About Amdocs

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.